Times Square Capital Management, LLC Astrazeneca PLC Transaction History

Times Square Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $4.53 Million - $5.18 Million	-130,330 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $172,750 - $185,250	5,000 Added 3.99%	130,330 $4.58 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $876,672 - $973,991	26,590 Added 26.93%	125,330 $4.38 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $722,506 - $783,071	22,515 Added 29.54%	98,740 $3.43 Million
Q3 2017 Nov 09, 2017	BUY	$28.96 - $34.0 $2.21 Million - $2.59 Million	76,225	76,225 $2.58 Million

1,356

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.